Fisher Scientific Reports Record Sales and Cash Flow


Fisher Scientific International Inc. reported its results for the fourth quarter and full year that ended 2004. Highlights of Fisher's performance in 2004 include record sales of $4,662.7 million, a 30.8 percent increase over 2003, and record operating cash flow of $392.8 million.

"We had an outstanding year, achieving record sales due to strong organic growth in our largest business -- scientific products and services -- and contributions from Apogent, Oxoid and Dharmacon," said Paul M. Montrone, chairman and chief executive officer. "We have made considerable progress on the integration of Apogent and are excited about our growth opportunities for 2005 and beyond."

Other news from the department business & finance

Most read news

More news from our other portals

Vis-à-Vis with UV/VIS